Imperial Brands H2 Earnings Call Highlights

Imperial Brands (LON:IMB) reported a sixth consecutive year of growth in tobacco and next-generation product revenue and adjusted operating profit, as higher cigarette prices offset falling volumes and its newer nicotine products gained market share.

For fiscal 2026, tobacco and next-generation product net revenue rose 2.1%, while adjusted operating profit increased 3.7% at constant currency, Chief Financial Officer Murray McGowan said. Adjusted earnings per share grew 8.8%, helped by profit growth and a lower share count following buybacks.

The company generated £2.6 billion in free cash flow, raised its dividend 4% and increased its planned share buyback to £1.5 billion for fiscal 2027, from £1.45 billion in fiscal 2026.

Pricing offsets lower tobacco volumes

Tobacco net revenue increased 1.7% as a 5.1% benefit from price and product mix more than offset a 3.4% decline in volumes, McGowan said. In the Americas, price and mix gains of 8.1% outpaced a 4.8% volume decline, contributing to a 3.3% rise in tobacco net revenue.

Chief Executive Officer Lukas Paravicini said the company responded to competition in lower-priced U.S. cigarettes by raising prices on its Crown brand and launching Malibu in the deep-discount segment. He declined to forecast U.S. volumes for fiscal 2027 but described the market as attractive.

In Germany, Imperial expects a higher-than-usual excise tax increase in January to affect volumes in fiscal 2027. Paravicini said the company could manage an additional profit impact of up to £20 million beyond what it had already included in its plans, supported by its portfolio of brands and markets.

Adjusted operating profit growth accelerated to 5.9% year over year in the second half, from 0.6% in the first half. Management attributed the improvement to factors including the effect of earlier price increases, a return to Syria, initial transformation benefits and a reduced impact from items that weighed on the first half.

Fiscal 2027 outlook points to stronger second half

Imperial expects low-single-digit tobacco net revenue growth and double-digit next-generation product revenue growth in fiscal 2027. It forecasts adjusted operating profit growth similar to fiscal 2026, within its 3% to 5% target range, and at least high-single-digit adjusted earnings-per-share growth, at constant currency.

Free cash flow is expected to be at least £2.2 billion. McGowan said the forecast reflects an expected reversal of working-capital benefits from fiscal 2026 and higher cash spending on the transformation program.

Management expects results to be more heavily weighted toward the second half than in fiscal 2026. First-half factors include investment in the acquired Black Buffalo and Helwit businesses and continuing supply-chain disruption in Ukraine after attacks on a factory and a third-party warehouse.

McGowan said the factory was operating again, but replenishing stock would take time. The company expects the full effect of pricing, transformation savings and duty drawback benefits to support the second half. Paravicini said duty drawback benefits should build swiftly during that period, with the full-year effect visible in fiscal 2028.

Smokeless reporting and transformation

Next-generation product net revenue rose 14.1% excluding the U.S. vapor exit, while losses narrowed by £5 million. McGowan said a growing contribution from Europe and improved gross margins were partly offset by investment in U.S. modern oral products following the Black Buffalo acquisition.

From fiscal 2027, Imperial will report a new smokeless category combining its existing next-generation products business with its traditional oral nicotine business in the Nordics. On that combined basis, the category had fiscal 2026 net revenue of £554 million and adjusted operating profit of £14 million. The company said it will continue to report next-generation product revenue separately.

Paravicini said Imperial delivered £90 million of annualized transformation savings in the first year and had taken actions expected to deliver another £90 million. During the presentation, the company described its 2030 savings target as at least £300 million; in the question-and-answer session, McGowan referred to a target of at least £320 million.

Imperial completed programs in fiscal 2026 that will lead to a reduction of 2,100 roles globally and expects a further reduction of 2,100 to 2,500 roles by the end of 2030, Paravicini said.

About Imperial Brands (LON:IMB)

We are a global consumer-focused business with a distinctive challenger role in the fast-transforming nicotine products industry. Through our 2030 strategy we are driving a consistent and sustainable performance from our portfolio of combustible products and building scale in smoke-free alternatives. We’re enabling stronger delivery against these priorities by getting closer to our consumers, building differentiated brands and innovating with agility. And we’re developing a high-performance culture and investing in tech and data to make faster.